Vol 45, No 4 (2014)
Prace poglądowe / Reviews
Published online: 2014-10-01

open access

Page views 173
Article views/downloads 401
Get Citation

Connect on Social Media

Connect on Social Media

Antifungal prophylaxis in children undergoing hematopoietic stem cell transplantation

Krzysztof Kałwak
DOI: 10.1016/j.achaem.2014.11.001
Acta Haematol Pol 2014;45(4):354-359.


Invasive fungal infections (IFI) remain a very important cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT) in children. The recent study from Polish pediatric transplant centers revealed that 27.3% of children transplanted in 2012–2013 developed IFI. The highest risk was observed among patients with AML and ALL after allogeneic HSCT. Such results warrant the use of extensive antifungal prophylaxis in this cohort of patients. ECIL-4 guidelines for antifungal prophylaxis in children undergoing HSCT along with clinical practice are presented in the review. Furthermore preventive measures for patients discharged home after HSCT are discussed.

Article available in PDF format

View PDF (Polish) Download PDF file